Literature DB >> 16142346

Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas.

Hio Chung Kang1, Il-Jin Kim, Jae-Hyun Park, Yong Shin, Sang-Geun Jang, Sun-A Ahn, Hye-Won Park, Sun-Kyung Lim, Seung Keun Oh, Dae Jung Kim, Kwan Woo Lee, Young-Sik Choi, Young Joo Park, Min Ro Lee, Duck-Woo Kim, Jae-Gahb Park.   

Abstract

Von Hippel-Lindau (VHL) disease is an autosomal dominant inherited tumor syndrome associated with germline mutations in the VHL gene. VHL disease, as well as several other cancer syndromes, has been associated with an increased risk of pheochromocytomas, which are catecholamine-secreting tumors of the adrenal gland. VHL disease genotype-phenotype correlations have been well established based on the type of mutations in the VHL gene. However, although many groups have reported VHL germline mutations in different countries, no previous report has described VHL gene mutations in VHL disease and/or pheochromocytoma patients in Korea. In this study, we used direct sequencing to investigate VHL germline mutations in Korean patients with VHL disease or pheochromocytomas (11 VHL patients and 3 additional members from 7 families, 2 patients from 1 family with familial pheochromocytoma, and 2 cases of isolated pheochromocytoma). We found a total of 7 VHL germline mutations (6 missense and 1 frameshift), 3 of which were novel (323_324delGC, 355T>C and 361G>A). No VHL germline mutation was found in the 2 patients with isolated pheochromocytomas and paragangliomas. This study provides informative data for VHL germline mutations and VHL-related phenotypes in Korea.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142346

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?

Authors:  Fatemeh Azimi; Ali Aghajani; Golnaz Khakpour; Samira Chaibakhsh
Journal:  Mol Genet Genomics       Date:  2022-08-25       Impact factor: 2.980

2.  Pancreatic involvement in Korean patients with von Hippel-Lindau disease.

Authors:  Kwang Hyuck Lee; Jae Seung Lee; Bum Jin Kim; Jong Kyun Lee; Seong Hyun Kim; Seung Hoon Kim; Kyu Taek Lee
Journal:  J Gastroenterol       Date:  2009-03-31       Impact factor: 7.527

3.  Germline mutation of Glu70Lys is highly frequent in Korean patients with von Hippel-Lindau (VHL) disease.

Authors:  Sena Hwang; Cheol Ryong Ku; Ji In Lee; Kyu Yeon Hur; Myung-Shik Lee; Chul-Ho Lee; Kyo Yeon Koo; Jin-Sung Lee; Yumie Rhee
Journal:  J Hum Genet       Date:  2014-07-31       Impact factor: 3.172

4.  A novel mutation in the von hippel-lindau tumor suppressor gene identified in a patient presenting with gestational diabetes mellitus.

Authors:  Yun Hyi Ku; Chang Ho Ahn; Chan-Hyeon Jung; Jie Eun Lee; Lee-Kyung Kim; Soo Heon Kwak; Hye Seung Jung; Kyong Soo Park; Young Min Cho
Journal:  Endocrinol Metab (Seoul)       Date:  2013-12-12

5.  Improved detection of germline mutations in Korean VHL patients by multiple ligation-dependent probe amplification analysis.

Authors:  Hyun-Jung Cho; Chang-Seok Ki; Jong-Won Kim
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

6.  One genotype, many phenotypes: SDHB p.R90X mutation-associated paragangliomas.

Authors:  Ali S Alzahrani; Meshael Alswailem; Yosra Moria; Ayman Aldeheshi; Hindi Al-Hindi
Journal:  Endocrine       Date:  2020-08-17       Impact factor: 3.633

7.  Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma.

Authors:  Shatha Albattal; Meshael Alswailem; Yosra Moria; Hindi Al-Hindi; Majed Dasouki; Mohamed Abouelhoda; Hala Aba Alkhail; Entissar Alsuhaibani; Ali S Alzahrani
Journal:  Oncotarget       Date:  2019-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.